Company profile
TeraRecon, Inc.
TeraRecon, Inc. has 4 AI-enabled medical devices on the FDA list. The first decision was on July 12, 2019 and the most recent on January 23, 2025 (TeraRecon Aorta.CT (1.1.0)). Its most common review panel is Radiology (4 devices).
4AI devices
2019First decision
2025Latest decision
1Specialties
Per year
2019202020222025
By specialty
Related guides
Timeline
- TeraRecon Aorta.CT (1.1.0) · Radiology · QIH
- TeraRecon Neuro · Radiology · LLZ
- Neuro.Al Algorithm · Radiology · LLZ
- iNtuition-Structural Heart Module · Radiology · LLZ